LexDanaLexDanabeta
New SessionSearchOfficial RankingsInsightsPricing
© LexDana · beta
LexDanaLexDanabeta
New SessionSearchOfficial RankingsInsightsPricing
LexDanaLexDanabeta

Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

AllCopyright & Trade Secrets14Federal Circuit179Pharma & ANDA40PTAB150Supreme Court9USPTO Policy27Patent Litigation55Patent Prosecution20ITC / Section 33732Trademark43Unsorted35

Tagged ptab decisions · clear

PTAB

Fresh From the Bench: Latest Precedential Patent Cases

CASE OF THE WEEK Merck Serono S.A. v. Hopewell Pharma Ventures, Inc. , Appeal Nos. 2025-1210, -1211 (Fed. Cir. Oct. 30, 2025) In our Case of the Week, the Federal Circuit upheld a Patent Trial and Appeal Board decision invalidating claims on Merck’s…

November 3, 2025·PTAB·2 min read
PTAB

Uncovering the Top 10 Most Contested IPC Codes in PTAB Litigation

Patexia has recently launched its 2024 PTAB Intelligence Report , offering a detailed analysis of the latest trends and developments in Patent Trial and Appeal Board (PTAB) proceedings. As the intellectual property landscape evolves, PTAB continues to play…

October 3, 2024·PTAB·4 min read
LexDana
AskSearchRankingsInsightsPricingProfileContactTermsPrivacy
The LexDana Docket
Monthly — what shipped, who moved, what we published.
© 2026 LexDana, Inc.·Powered by Patexia data